198 related articles for article (PubMed ID: 20863406)
41. Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors.
Van Dyck P; Vanhoenacker FM; Vogel J; Venstermans C; Kroon HM; Gielen J; Parizel PM; Bloem JL; De Schepper AM
Eur Radiol; 2006 Dec; 16(12):2644-51. PubMed ID: 16612549
[TBL] [Abstract][Full Text] [Related]
42. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis.
Wetzel LH; Levine E
AJR Am J Roentgenol; 1990 Nov; 155(5):1025-30. PubMed ID: 2120930
[TBL] [Abstract][Full Text] [Related]
43. [An ultrastructural analysis of malignant soft tissue tumors].
Tsuneyoshi M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1577-83. PubMed ID: 3592702
[TBL] [Abstract][Full Text] [Related]
44. Treatment of soft-tissue sarcomas of the hand.
Brien EW; Terek RM; Geer RJ; Caldwell G; Brennan MF; Healey JH
J Bone Joint Surg Am; 1995 Apr; 77(4):564-71. PubMed ID: 7713973
[TBL] [Abstract][Full Text] [Related]
45. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
46. Clinical features of soft tissue sarcoma presenting intra-tumour haematoma: case series and review of the literature.
Hoshi M; Oebisu N; Ieguchi M; Ban Y; Takami M; Nakamura H
Int Orthop; 2017 Jan; 41(1):203-209. PubMed ID: 27826764
[TBL] [Abstract][Full Text] [Related]
47. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and diagnostic significance of fluid-fluid levels in soft-tissue neoplasms.
Alyas F; Lee J; Ahmed M; Connell D; Saifuddin A
Clin Radiol; 2007 Aug; 62(8):769-74; discussion 775. PubMed ID: 17604765
[TBL] [Abstract][Full Text] [Related]
49. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
Kang S; Han I; Lee S; Kim W; Kim H
Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
[TBL] [Abstract][Full Text] [Related]
52. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
Issakov J; Merimsky O; Gutman M; Kollender Y; Lev-Chelouche D; Abu-Abid S; Lifschitz-Mercer B; Inbar M; Klausner JM; Meller I
Ann Surg Oncol; 2000 Mar; 7(2):155-9. PubMed ID: 10761796
[TBL] [Abstract][Full Text] [Related]
53. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging.
Biondetti PR; Ehman RL
Radiology; 1992 Jun; 183(3):845-8. PubMed ID: 1584945
[TBL] [Abstract][Full Text] [Related]
54. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
55. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
[TBL] [Abstract][Full Text] [Related]
56. Primary sarcomas of the lung: a clinicopathologic study of 12 cases.
Etienne-Mastroianni B; Falchero L; Chalabreysse L; Loire R; Ranchère D; Souquet PJ; Cordier JF
Lung Cancer; 2002 Dec; 38(3):283-9. PubMed ID: 12445750
[TBL] [Abstract][Full Text] [Related]
57. Soft-tissue sarcoma mimicking large haematoma: a report of two cases and review of the literature.
Niimi R; Matsumine A; Kusuzaki K; Okamura A; Matsubara T; Uchida A; Fukutome K
J Orthop Surg (Hong Kong); 2006 Apr; 14(1):90-5. PubMed ID: 16598096
[TBL] [Abstract][Full Text] [Related]
58. Analysis of soft tissue sarcomas in 1118 cases.
Fang ZW; Chen J; Teng S; Chen Y; Xue RF
Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
[TBL] [Abstract][Full Text] [Related]
59. MRI of soft-tissue masses: the relationship between lesion size, depth, and diagnosis.
Datir A; James SL; Ali K; Lee J; Ahmad M; Saifuddin A
Clin Radiol; 2008 Apr; 63(4):373-8; discussion 379-80. PubMed ID: 18325355
[TBL] [Abstract][Full Text] [Related]
60. Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies.
Cecchetto G; Alaggio R; Dall'Igna P; Bisogno G; Ferrari A; Gigante C; Casanova M; Sotti G; Zanetti I; Carli M
Cancer; 2005 Nov; 104(9):2006-12. PubMed ID: 16161038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
